CHAM
PROF

Clear Harbor Asset Management’s Profound Medical PROF Stock Holding History

Clear Harbor Asset Management’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-500
Closed -$8.77K – 628
2020
Q3 		$8.77K Buy
+500
New +$7.95K ﹤0.01% 605

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
BC
Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Clear Harbor Asset Management's PROF Position: Q4 2020 in Review

Clear Harbor Asset Management sold out of Profound Medical (PROF) in Q4 2020, closing a stake of 500 shares — an estimated $8.77K sold.

Clear Harbor Asset Management first reported a position in PROF in Q3 2020 and held it in 1 quarter. The position peaked at $8.77K in Q3 2020. 56 funds tracked by Wall St. Rank hold PROF as of Q4 2020.

  • Clear Harbor Asset Management reported no remaining Profound Medical position as of Q4 2020 after selling out during the quarter.
  • Clear Harbor Asset Management sold 500 Profound Medical shares in Q4 2020, an estimated $8.77K.
  • Clear Harbor Asset Management first reported a position in Profound Medical in Q3 2020 and held it in 1 quarter.
  • Clear Harbor Asset Management's Profound Medical position peaked at $8.77K in Q3 2020.
  • 56 funds tracked by Wall St. Rank held Profound Medical as of Q4 2020.

Based on Clear Harbor Asset Management's 13F filing for Q4 2020, filed 4 Feb 2021.